
UNH
UnitedHealth Group Incorporated · NYSE
$512.60+0.97%
9 Sep close- Market cap
- $472B
- Sector
- Health care
Income statement
Revenue, costs and earnings
Loading

| Twelve months to | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period ending | 30 Sep 23 | 31 Dec 23 | 31 Mar 24 | 30 Jun 24 | 30 Sep 24 | 31 Dec 24 | 31 Mar 25 | 30 Jun 25 | 30 Sep 25 | 31 Dec 25 | 31 Mar 26 | 30 Jun 26 | Each line by period |
| Revenue | $359.1B | $371.6B | $378.4B | $385.5B | $392.7B | $400.3B | $407.0B | $414.0B | $421.0B | $428.5B | $435.5B | $442.8B | |
| Cost of revenue | −$274.9B | −$284.8B | −$290.4B | −$296.2B | −$302.1B | −$308.4B | −$313.9B | −$319.7B | −$325.6B | −$331.7B | −$338.0B | −$344.5B | |
| Gross profit | $84.2B | $86.8B | $88.0B | $89.3B | $90.6B | $91.9B | $93.1B | $94.3B | $95.5B | $96.8B | $97.5B | $98.3B | |
| Operating costs | −$36.5B | −$37.8B | −$38.3B | −$38.8B | −$39.4B | −$39.9B | −$40.6B | −$41.3B | −$42.0B | −$42.7B | −$42.4B | −$42.1B | |
| Cost of products sold | −$15.3B | −$15.8B | −$16.1B | −$16.3B | −$16.5B | −$16.7B | −$17.0B | −$17.3B | −$17.6B | −$17.9B | −$17.8B | −$17.6B | |
| Depreciation and amortisation | −$7.0B | −$7.3B | −$7.4B | −$7.5B | −$7.6B | −$7.7B | −$7.8B | −$8.0B | −$8.1B | −$8.3B | −$8.2B | −$8.1B | |
| Restructuring and other charges | −$1.9B | −$2.1B | −$2.3B | −$2.5B | −$2.6B | −$2.9B | −$2.6B | −$2.3B | −$1.9B | −$1.6B | −$2.3B | −$3.0B | |
| Operating income | $23.4B | $23.8B | $24.0B | $24.2B | $24.4B | $24.7B | $25.1B | $25.5B | $25.9B | $26.3B | $26.9B | $27.4B | |
| Operating margin | 6.5% | 6.4% | 6.3% | 6.3% | 6.2% | 6.2% | 6.2% | 6.2% | 6.1% | 6.1% | 6.2% | 6.2% | |
| Other income and expense, net | −$1.1B | −$1.1B | −$1.2B | −$1.2B | −$1.3B | −$1.3B | −$1.4B | −$1.4B | −$1.5B | −$1.6B | −$1.7B | −$1.8B | |
| Income before taxes | $22.3B | $22.7B | $22.8B | $23.0B | $23.2B | $23.4B | $23.7B | $24.0B | $24.4B | $24.7B | $25.2B | $25.7B | |
| Income tax expense | −$5.1B | −$5.2B | −$5.2B | −$5.2B | −$5.3B | −$5.3B | −$5.4B | −$5.5B | −$5.6B | −$5.7B | −$5.8B | −$5.9B | |
| Net income | $17.2B | $17.5B | $17.6B | $17.8B | $17.9B | $18.0B | $18.3B | $18.5B | $18.8B | $19.1B | $19.4B | $19.8B | |
| Diluted shares, billions | 0.94 | 0.94 | 0.94 | 0.94 | 0.93 | 0.93 | 0.93 | 0.93 | 0.93 | 0.93 | 0.92 | 0.92 | |
| Diluted earnings per share | $18.34 | $18.67 | $18.77 | $18.89 | $19.25 | $19.36 | $19.66 | $19.92 | $20.19 | $20.57 | $21.10 | $21.49 | |
| Derived metrics | |||||||||||||
| Revenue growth, period on period | no prior period | +3.5% | +1.8% | +1.9% | +1.9% | +1.9% | +1.7% | +1.7% | +1.7% | +1.8% | +1.6% | +1.7% | |
| Gross margin | 23.4% | 23.4% | 23.3% | 23.2% | 23.1% | 23.0% | 22.9% | 22.8% | 22.7% | 22.6% | 22.4% | 22.2% | |
| Net margin | 4.8% | 4.7% | 4.7% | 4.6% | 4.6% | 4.5% | 4.5% | 4.5% | 4.5% | 4.4% | 4.5% | 4.5% | |
Billions of dollars, except earnings per share in dollars and the share count in billions. Growth is on the period before.